Dexmedetomidine Wound Infiltration in Cesarean Section
Status:
Active, not recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The effects of four different wound infiltration protocols in cesarean section will be
investigated on parturient' pain intensity, PCA morphine consumption given, side effects and
parturient' overall satisfaction.
One group will receive for wound infiltration dexmedetomidine, the second ropivacaine, the
third dexmedetomidine combined with ropivacaine, while the last one will receive normal
saline (placebo group).